OptiCare Reports Third Quarter 2004 Financial Results WATERBURY,
Conn., Nov. 15 /PRNewswire-FirstCall/ -- OptiCare Health Systems,
Inc. (AMEX:OPT) announced today that it reported total net revenues
for the nine months ended September 30, 2004 of $88.3 million, down
from $95.7 million for the nine months ended September 30, 2003 and
total net revenues for the three months ended September 30, 2004 of
$27.9 million, down from $32.3 million for the three months ended
September 30, 2003. The Company also reported a loss from
continuing operations for the nine months ended September 30, 2004
of $2.7 million, down from a loss from continuing operations of
$10.5 million for the nine months ended September 30, 2003; loss
from continuing operations for the three months ended September 30,
2004 of $1.8 million, down from a loss from continuing operations
of $8.4 million for the three months ended September 30, 2003; net
loss to common stockholders for the nine months ended September 30,
2004 of $4.6 million, down from a net loss to common stockholders
of $11.0 million for the nine months ended September 30, 2003; and
net loss to common stockholders for the three months ended
September 30, 2004 of $2.4 million, down from a net loss to common
stockholders of $8.6 million for the three months ended September
30, 2003. About OptiCare Health Systems, Inc. OptiCare Health
Systems, Inc. is an integrated eye care services company focused on
vision benefits management and the distribution of products to eye
care professionals, and consumer vision services, including
medical, surgical and optometric services and optical retail. This
press release may contain forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. These statements include, but are not limited
to, statements containing words such as "plan," "anticipate,"
"expect," "intend," "believe," "will," or similar expressions. The
company's actual results could differ materially from those
expressed or indicated by any forward-looking statements. Factors
that could cause or contribute to such differences include, but are
not limited to, the impact of the restatements, the reaction of the
company's stockholders, customers, venders and lenders to the
reviews and restatements, the risk that the company may not be able
to improve cash flow, may not be able to successfully integrate its
acquisitions, to retain and attract qualified employees, the impact
of current and future governmental regulations in existing lines of
business, the company's ability to successfully and profitably
manage its operations and growth of the operations, if any, the
risks related to managed care contracting, and the ability of the
company to successfully raise capital on commercially reasonable
terms, if at all. Investors are cautioned that all forward-looking
statements involve risks and uncertainties, including those risks
and uncertainties detailed in the company's filings with the
Securities and Exchange Commission, including its Annual Report on
Form 10-K/A for the fiscal year ending December 31, 2003.
Forward-looking statements speak only as of the date they are made,
and the company undertakes no duty or obligation to update any
forward-looking statements in light of new information or future
events. OPTICARE HEALTH SYSTEMS, INC. AND SUBSIDIARIES Condensed
Consolidated Balance Sheets (Amounts in thousands) (Unaudited)
September December September 30, 2004 31, 2003 30, 2003 ASSETS As
Restated CURRENT ASSETS: Cash and cash equivalents $2,950 $1,695
$2,233 Accounts receivable, net 7,989 7,867 10,025 Inventories
5,160 5,770 6,296 Assets held for sale - 1,652 1,535 Other current
assets 1,174 565 592 TOTAL CURRENT ASSETS 17,273 17,549 20,681
Property and equipment, net 3,732 4,647 5,180 Goodwill, net 17,917
17,892 18,231 Intangible assets, net 1,096 1,179 1,207 Assets held
for sale, non-current - 1,339 1,475 Other assets 3,531 3,249 2,990
TOTAL ASSETS $43,549 $45,855 $49,764 LIABILITIES AND STOCKHOLDERS'
EQUITY CURRENT LIABILITIES: Accounts payable $8,739 $5,525 $8,705
Accrued expenses 7,050 5,379 6,284 Current portion of long-term
debt 10,090 10,828 9,057 Liabilities of held for sale business -
1,241 1,324 Other current liabilities 950 548 421 TOTAL CURRENT
LIABILITIES 26,829 23,521 25,791 Long-term debt, less current
portion 78 1,775 1,549 Other liabilities 513 512 522 TOTAL
NON-CURRENT LIABILITIES 591 2,287 2,071 Series B 12.5% mandatorily
redeemable, convertible 6,163 5,635 5,476 preferred stock-related
party STOCKHOLDERS' EQUITY: Series C preferred stock- related party
1 1 1 Common stock 31 30 30 Additional paid-in-capital 79,347
79,700 79,853 Accumulated deficit (69,413) (65,319) (63,458) TOTAL
STOCKHOLDERS' EQUITY 9,966 14,412 16,426 TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY $43,549 $45,855 $49,764 OPTICARE HEALTH
SYSTEMS, INC. AND SUBSIDIARIES Condensed Consolidated Statements of
Operations (Amounts in thousands, except share data) (Unaudited)
Three Months Nine Months Ended Ended September 30, September 30,
2004 2003 2004 2003 NET REVENUES: Managed vision $6,547 $7,118
$18,864 $22,006 Product sales 16,615 20,023 52,452 56,961 Other
services 4,776 4,809 15,236 13,982 Other income - 352 1,718 2,720
Total net revenues 27,938 32,302 88,270 95,669 OPERATING EXPENSES:
Medical claims expense 4,914 5,993 14,274 17,250 Cost of product
sales 12,937 15,683 40,900 44,251 Cost of services 1,870 2,024
6,338 5,922 Selling, general and administrative 9,231 9,749 27,248
27,488 Goodwill impairment loss - 1,300 - 1,300 Loss from early
extinguishment of debt - - - 1,847 Depreciation 432 632 1,243 1,334
Amortization 27 29 83 87 Interest 300 330 896 1,719 Total operating
expenses 29,711 35,740 90,982 101,198 Loss from continuing
operations before taxes (1,773) (3,438) (2,712) (5,529) Income tax
expense (benefit) (20) 5,001 32 4,929 Loss from continuing
operations (1,753) (8,439) (2,744) (10,458) Discontinued operations
Loss from discontinued operations (including loss on disposal of
$1,005 in 2004) (421) (57) (1,350) (52) Income tax benefit - 20 -
18 Loss on discontinued operations (421) (37) (1,350) (34) Net loss
(2,174) (8,476) (4,094) (10,492) Preferred stock dividends (177)
(159) (528) (459) Net loss to common stockholders $(2,351) (8,635)
$(4,622) $(10,951) LOSS PER SHARE- BASIC AND DILUTED: Loss from
continuing operations $(0.06) $(0.29) $(0.11) $(0.37) Discontinued
operations (0.02) 0.00 (0.04) 0.00 Net loss (0.08) (0.29) (0.15)
(0.37) DATASOURCE: OptiCare Health Systems, Inc. CONTACT: Vincent
S. Miceli, Director of External Reporting of OptiCare Health
Systems, Inc., +1-203-596-2236
Copyright
Opticare Health (AMEX:OPT)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Opticare Health (AMEX:OPT)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024